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CHAPTER

I

INTRODUCTION

AND
STAT»fENT OF THE PROBLEl'.f

Investigators in recent years have shown more and more the importance of enzymes in bodily processes.

Receiving equal attention of in-

vestigators are the enzyme inhibitors. Since the beginning of the twentieth century it has been known that an1mal and human sera have an antiproteolytic enzyme action.

This phenomenon has been investigated in re-

lation to many diseased states, among which are included those with a
common gro'tll'ld of severe inflammatory a.ctivity or tissue necrosis.

The

importance of certain ensyme activities in inflammation has aJ.so been established.

Investigations have been performed which show the presence of

proteolytic eM)'me inhibitors in animal and human tissues.

Ultimately,

it 'tfOuld seem that the proper functioning of bodily processes is greatly
dependent upon the interrelationship .of enzymes and their inhibitors.
The purpose of this investigation was to study the activity

or

pro-

teolytic enz,.es in human gingival tissue under normal and in chronically inflamed condi tiona in light of the available information regarding proteolytic enzyme inhibitors.

Since little methodology in respect to this type of investigation is
present in the literature, the develoJlllent of a workable technic is considel"6d to be an important part of this study.

-1-

CHAPl'ER

II

REVIEW <F THE LITERATURE

Studies of the antiproteolyt1c activity of tissues have been preceded by the investigation of the antiproteolYtic activity of the serum
of animals and h'J.II\MII.

Thia field of investigation is closely related

to

the problem of this paper and a review o£ the literature of the antiproteolytic action of the serum will provide a. fuller understandiJ'!.g of the
present problem under investigation.
Hildebrandt (189.3), Camus and Gle,. (1897) and Landsteiner (19OO) have
been credited bY' other reviewers of the literature for the first observations of the inbib1tory power of serum on the action of trypsin.

However,

review of these publications shows that the experimental technic involved
in these works was primarily the injection of an enzyme, which is protein
in natur.e, into experimental animals.

The reactions observed were inhibl-

tor.r to be sure, but :lUSt be interpreted as an antibody reaction to the

protein nature of the

enz~e.

The~e

l1orks, therefore, do not demonstrate

the presence of an enzl'TIe-ant1enzyme reaction with which this paper is concerned as stated in the first chapter.
Opie (1905) studied the enzy.rnatic ond. LYltienzymatic a.ction of in-

flammatory exudates, by production of experimental inflammatory reactions
in the peritoneal cavities of experimental ani.m.a1s.

By collect.ing the

leukocytes produced in the inflam'natory procesS and allowing the auto-

lysis of these cells, he determined the proteolytic enzyme activity of
-2.

-3the leukocytes.

Opis was able to demonstrate the inhibitory effect of

blood sertll1 and inf'lammatory exudates upon the enzyme leukoprotease of
the leukocytes by incubation of these with the leukocytes.

Fram this the

conclusion was made that serum had the power of inhibiting proteolytic enzymes of the leukocytes and that this inhibitor probably passed into the
exudates of the inflammatory process.

In· the later stages of 1.n:fl.amma-

tion there was sane diminution of the antienzymatic action.
HUssey and Northrop
the blood.

(1922) investigated the antitryptiC activity or

They found that the inhibitory agent and trypsin combine to

form an inactive but dissociable compound.

'rhe reaction in equilibrium

could be expressed by the equations
Trypsin + inhibitor

~ trypsin.inhibitor

These investigators stated that the corniitiona of equillbrilll'll are governed by the law of mass action.

RUnitz and Northrop

(1936) developed a method

trypsin inhibitor from beef pancreas.
trypsin but to a lesser extent.

of crystallization of a

The inhibitor also inhibited chymo-

The inhibitor displqed the general

properties of a polypeptide.
~b

(1943) studled the nature and e:xperimental variation of the anti....

proteolytic activity of serum. by intravenous, intramuscular and oral administration of trypsin in rabbits.

He fotmd that intramuscular admlnls-

tration of trypsin resulted in a slow rise in the antiproteolytic activity
of the serum. followed by a lesser decline.
sulted in no anpreciable variation.

Intravenous administration re-

Oral a.dministration resulted in a

-4rapid

rise~

tramuscular~

which was sustained during the period of administration.

In-

intravenous and oral administration of denatured tlj'PSin re-

sulted in no appreciable variation.
Determinations of antiproteolytic activity of the serun were made by
the degradation of casein and by a proposed experimental formula devised
by author. From these facts and from the findings of Kunitz and Northrop,
mentioned above, Grob attached. important Significance to the products of
protein hydrolysis both in the intestine and parenterally in relation to
the antiproteolytic activity of the serum.

On the basis of the nature and

magnitude of the experimental variations obtained in his work and on the
lack of parallelism between precipitin tests performed on the animals and
antiprotease activity, Grob stated that antibodies to trypsin were not an
important factor in the antiproteolytic activity of the serum.
Investigating further the nature of the antiproteolytic substance
in the serum, Grob (1945-46) presented evidence that leukoprotease and

trypsin are inhibited by reducing agents, including thiol-sulfhydryl compounds and ascorbic acid.

It was shown that the antiproteolytic activity

was largely confined to the albumin fraction of sel"llrl.
the inhibitory factor was not diaJ.ysable.

According to Grab

fhe reported fact that the anti-

proteolytic factor was not freely diffusible in the body except when inflammatory or other pathologic processes increase capillary permeability,
is in agreement with the conclusion of Opie.

Dutherie and Laurenz (1949) supported the findings that the serum.
antiprotease is associated with all the serum protein fractions but main-

-5ly 'tnth the most soluble albumin fraction.

trypsin inhibitor

v..'"S.S

They also found that the serum.

relatively stable but was sensitive to the lowering

of pH, which is in agreement with the findings of' Grob (1945). Dutherie
and Lorenz were unable to reproduce the results of Grob concerning the

variations of the antitryptic levels of serum, by the administration of
trypsin.

In their studies there was only a 15% increase in the anti-

trypsin activityof' serum after four weeks of subcutaneous administration
in rabbits.

No incres.se

~ras

observed after oral administration.

Rusk and Cllffton (195.1) investigated the relationship of the antiproteolytic activity of serum with the fibrinolytic activity.

».r in-

jecting 80ybean trypsin inhibitor of Kunitz and Northrop intravenously in..
to mice they were able to increase the antitryptic activity of the serum.
The changes were observed for a. week or longer following the injections,
indicating the slow destruction or excretion of the so,Ybean inhibitor in
Vivo.
The relation of a polypeptide structure to the antiproteolytic faetor in serum has been reported often in the literature.

Ungar and Adler

(1956) have reported the discovery of a peptidase in guinea pig serum
whose activity closely parallels the guinea pig serum protease inhibition.
The action of the peptidase is detectable by its action on a chranogenic
substrate glycyl-beta-naphthyla'line.

Competitive inhibition of the pep-

tidase action by both plasmin and trypsin suggested that the proteases
were substrates for the peptidase and. that the antiproteolytic activity
of guinea pig serum 'Was due, at least in part, to the enzymatic destruction of proteases. "fuile this phenanenon was found to be present in

-6other species including man, its relationship to 'protease inhibitiOn was
not as marked.
In discussing proteolytic enzyme inhibitors John Bodman (1958)
specifies the presence of two separate inhibitors for trypsin and chymotryps in.

According to Bodman both could be separated by curtain electro-

phoresis.

The trjlpSin inhibitor appeared in several fractions and the

chymotrypsin "las always collected in the fraction between the oc..l globulins and the albumin.

Bodman suggested that the serum inhibitor titers

might poss :Lbly be under hormonal control.
Aizana (1960) conducted zone electrophoresis studies to determine the
relationship of tl7'PSin and chymotrypsin inhibitors to each other.

Using

a newly developed zone electrophoresis technic it was determined that the
grea.t~r

part of both trypsin and ch)'motr)'psin inhibitors migrated with the

alpha globulin fraction.

Sane inhibitory a.ctivity was found with the

cc2 globulin. Studies of the pathological. sera showed the same distribution of the inhibitors in the q 1 globulin.

The ratio of inhib:i.tor,y

activity between trypsin and chymotrypsin inhibitors in noma!
logical sera did not var:! significantly.

am

patho-

As a result of these findings

it ..raa concluded that the inhibitory activity against trypsin and chymotrypsin

lTas

exerted by a single inhibitory substance.

Vermeenko (1960) .found that serum and plasma inhibited trypsin activity to the same degree and whole blood was 30% less inhibitory. When
casein

~ras

used as a. substrate, the trypsin activity inhibition depended

upon the amount of plasma.

The add! tion of urea to casein substrate caused

-7a marked deviation £rom the linear dependence.

Curves representing tryp-

sin activity dependence pointed to the dissociation of the trypsin inhibitor complex.

The effect of urea on the complex dissociation indic-

ated the involvement of H bonds in the mechanism of the trypsin inhibitor
complex.

The dependence of the dissociation of the trypsin inhibitor

cc:mplex on the nature of the substrate shol,Ted th.:'l.t the substrates were
capable of competing with the inhibitor for the free

~JPBin.

A dynamic

equilibrium established itself between the trypsin and the inhibitor on
the one hand and the substrate on the other.
Thus far the presence of an antiproteolytic factor in the serum has

been eeta.blished tmd a beginning insight into its nature has been discus-

sed.

However, the problem of this "l'ork concerns the presence of a pro-

teolytic enzyme inhibitor in tissue.

Opis (1905) discusses the possibU-

ity ot the passage of the serum inhibitors into tissues in inflammatory
exudates.

This possibility has been confirmed in the literature.

HmoJ-

ever I the investigations of a tissue inhibitor have been tmderlaken only
recently and to a limited extent.
Astrup (1952) described a potent fibrinolytic inhibitor in ox lung

tissue "..bieh appeared to be an antiproteolytic substance.
Scevola, Calchi, 1'1ovati, and Felisati (1954) and Scevola a.."1d Felisatl

(1955) investigated human, rabbit, guinea pig and ox tissues which included lung, heart, liver, kidney, muscle, stomach, uterus and placenta.

The studies vlere done on h('W,\ogenates of these tissues.

Trypsin inhibi-

tion varied between tissues of the same animal and between species for

-8the identical tissue.

upon 20 minute contact trypsin inhibition by lung

was 90, 78, 35, 29 and 28% in ox, guinea pig, humans, rat and rabbit respectively.

The inhibition for heart tissue was 50,

42, 38, 34,

and

11%

for guinea pig, rat, ox, rabbit and humans; for pla.centa 67, 63, 26, 18
and

11% for humans, guinea pig, ox, rat,

and rabbit respectively.

Guinea

pig uterltil showed maJd.m.um inhibition; lowinhit)ition was shown for muscle,
stomach, kidney and liver tissues.
ed much less than trypsin.
havior.

In general, chymotrypsin was inhibit-

Human tumoral tissue shcr<iOO an irregular be-

The antit%7Ptic activity was sometimes lower, as in lung, and

sometimes higher, as in brain, than in nonnal tissue.
Astrup and Stage (1956) isolated and partially purified a protease
inhibitor from ox lung tissue.

The active caupound had a characteristic

themostability and was most stable at acid reaction and
neutral and alkaline reaction.

"TaB

destroyed at

These pH reactions are the reverse of

those of the serum antiproteolytic factor reported this far.
By subjecting tissue monocytes in a culture to an antigen-a.'"ltibody

reaction, Tokuda (1959) studied the proteolytic mechanism of the antigen
antibody reaction.

Sensitized rabbit monocytes were subjected to an anti-

gen-antibody reaction in a specially designed culture chamber and were
found to release a protease into the culture fluid.
and up to

48

Begin!1ing at

hours a proteolytic inhibitor was released.

hours

Evidence was

given that the inhibitor "Tas definitely of cellular origin.
L~~ibitor

24

The protease

was isolated and partially purified and found to also inhibit

the protease of euglobL, fractions prepared from the area of arthus-like

-9b;ypersensitivity and papain but not of trypsin.

It was pointed out that

both of these protease. had. an essential SH group.

'!'he inhibitor also

gave a slight Biuret reaction indicating that it might have been a polypeptide.

Although this study was essentially concerned 'r;rith t.he antigen-

antibody reaction of cells, viewed in the light of resronBf's to ce1J. 'llar

injury, it 113 particularl,'V interesting and me-y he reJ.e,ted. to the prohlem
studied in this paper.

The relationship of the antiproteolytic activity of the serum and
various disease states has been conf'imed in the literature.
earliest worl~, that of Opie

(1905),

tor l-l'ith the inflam.."!latery process.

One of the

implic~terl the antiproteol~~ic fac-

Rm-rever, one of the earliest investi-

gs,tiona correla.ting the antiproteolyt.ic activity of serum and the ir'..f.lam.matory process was thet of Hert

(1909).

He not~d that the inhibitory

ael'tlll levels were elevated in all the C8Ses of ir..fecM.ous dis€,ascs 8tudied.

The levels remained elevated through the
lescence had been fully established.
elevated in

pathologica~

~0urse

of infection until

conv~

Antitryptic levE>ls of serum -:-mre also

eases involving cellular destruction lilich were

not of infectious·causes.
An. ex.amination of 2,000 cases by l-lest and Hil1iatVI (1949) indicated

a relationship of proteolytic enzyme inhibition, specifically
~"'1d

ren.'1in, to numernu.s disease states.

In this study

e~otr:Y'ps1n

acut~ i'1f~ctious

conditions, influencing chymotrypsin inl'l.ibitors pre<iomirumtly, eO!'1:prised

24% or all of the cases studied.
The 'T/ork of Dillard and Chanutin (1949) established some facts :1hich

-10should be kept in mind.

This work studied serl,.w levels of proteolysin,

plasmin, and trypsin inhibitor of plasma. in cancer patients and a variety
of acute and chronic disease states.
"''38

evident in tha study.

No relationship be1ilreen all of these

However, both proteolysin and trypsin inhihitor

could be related to cancer and to acute infectious disease
evidenced by increased serlU11 level.

statt~S afJ

The trypsin inhibitor concentration

level remainr-d eleva.ted in those 11ho had been operated on and in those

whose tissues t·1ere tmdergoing readjustment to the normal state.
'1'a,uber (1950) found thl'l.t of cases exemined 8.1% of those with acute

1n:f'ections shmrod abnormal tests of chymotrypsin inh1bition.
~10

E:tght and

tenths per cent of those ",.nth chronic infections shwed cbnol"rM.1 levels.

CHA.P1'ER III
MATmIALS

AND ME.THODS

Th1a study 'Was performed upon sixteen subjects of whOtll nine oerved
as a control group and seven as an experimental group.

It was decided

to limit the study to male subjects in an age range from 25 to 35 years.

'l'his vms done to eliminate as much as possible variations result,ing fran
sex differences and variations vyhich might be attributable to aging pro-

cesses.

rhe medical histories of both the control and the experiment6.l.

subjects revealed no recent systemic diseases of consequence.

The con-

trol subjects were apparently healthy at the time of the study.
perimental subjects

'ti'eTe

The ex-

healthy aside from the periodontal disease.

'!'he tiBsue studied "Tas the attached gingiva.

Tissue specimens were

obtained from the vestibular and tnter-dental aspects of the pre-molar or
anterior teeth of either the maxilla or mandible.

The decision as to

'f.:'bieh area was to be biopsied was based upon clinical diagnosis.

The

areas biopsied in the subjects of the control or normal group shaw cli11iCl;' 1y normal gingival tissues.

The areas taken from the subjects in the

experimental group showed chronic inflam.ma.t.ion. An histological specimen,
stained 1Tith hE'matoxylin and eosin,

lias

made of €ach tissue sample to con-

firm the clinical diagnosis of -the state of the tissue.

Orban periodontal knives were used to excise the tissue specimens.
Anesthesia

w~s obtain~l

through infiltration of procaine

anesthetic ldth epinephrine 1:50,000 concentration.

t~ochloride

The injection was

made e.s far removed as possible from the sight of the operation.

-11..

The

-12specimen was 1-Tuhed in tap water and blotted dry'.

At this time a portion

was removed. from this specimen, fixed in 10% foma1in and prepared for

histologic examination as mentioned above.

ot the state of the tissue was determined
present

invest~ator.

The histological diagnosis
by an histologist other than the

The greater portion ot the specimen was placed into

a Petri dish, covered and placed in a freezer cmpartment at about -20 degreed Centigrade.

Proteolytic activity- of the specimen was determined

within the next twenty-tour hours as will be described he10101.

In most

instances, a sample of venous blood was also obtained in order to assess
the proteolytic behavior of the serum associated with the ICI'ing1val s"Oecimens.
!'he Method of Bodman (19$7) for the measurement of the proteolytic
enzyme inhibitor of serum was adapted to this study.

The principle in-

'Vo1ved in this method is to establish an enzyme,substrate model ot
concentration and reaction rate.

'!'his model served as a control.

mown
To

detemine whether tissue contained substances which arfect the rate of this
enzj'!llic acti'Vity, an homogeniSled tissue specimen of

mown weight

and con-

centration was allowed to incubate in contact with the determined amoutrli
of enz:vme tor a gi'Wm period of time.

This modified enzyme wes then in-

corporated into an enzyme •subs trate model.

The amount of hydrolysis ot

the subs trate by- the enzyme was determined tor both the control model 8l'ld
the e:x:perimental model whose enzyme constituent had been allowed to be
in contact with the homogenized tissue before acting upon the substrate.

Reagents for an enzyme.substrate model were prepared in the following manner.

Eight mg. of vitamin tree test casein code nunber CMX-1l55

-]3-

contributed by Abbott Laboratories were added to 180 ml. of distilled
water with 6.0 ml. of lJl sodium hydroxide.

'!'his was shaken in a stop-

pered wide-mouth fiask twenty times and allowed to stand for one hour at
l"OCIIl

tempe1"'ature.

'1'0

this emulsion was added 284 111. of distilled water,

a crystal of thymol and a few drops of octyl alcohol. !his solution is
both the substrate and the buffe of the syst_.
The eM3'lle used for this st'lldy was

The final pH is 7.6.

c~otrypsin.

Chymotrypsin wu

chosen as the proteolytic enzp!e hecause of the available knowledge about
it and because of the reliabUity of its reaction.

Seventy mg. of Cl78-

tallized ch1motrypain (1075 Armour lib un1ts/mgm.) contributed by Armour
Pharmaceutical Company were diluted in 250 ml. of 0.002 K bydrochloric
acid.

'!'hen 65.3 ml. of this enzyme solution were diluted to 100 ml. with

0.002 M hydrochloric acid.

This was temed the stock enzyme solution.

It could also be prepared by' weighing 18.3 mgm. of ch)1motr,psin and diluting it to 100 ml. with 0.002 K ~hloric acid.

a,drolywis studies

of the chymotrypsin with casein dem.Oll8trated that further dilution of the

stock enz,me solution was necessary in this studT, because of the great
activit,. of the eMp!e supplied to us. A ten-fold dilution was decided
upon.

It was prepared b,. dUuting 1 ml. of stock enzyme solution to 10

Ill. with 0.002 K hydrochloric acid.
enzyme solution.

This was then called the world.ng

Hydrolysis rates were determined and hydrolysis curves

were plotted. From these the
in this study were determined.

~Isubstrate

model eoncentratiOll8 used

Aliquots of the standard enzyme and work-

ing enz,.e were made according to the protocol shown in Table I.

Each

--

TABLE I
CHlMOTRYPSIN HYDROLYSIS STUDY

TABLE I
INCUBATE 2 HOURS AT 38

0

MIX LET STAND

SHAKE INCUBATE

C.

%TRANSMISSION

iClmrRlFUGE DECAN'!'

Casein

TCA 10%

Digest

Tube

Enzyme

HCL

Saline

1

5.0

2.. 5

2.,5

15

3

5

2

2.5

5.0

2.5

15

3

5

1.0
1 : 10
4
7.5
3

6.5

2.5

15

3

5

0

2.5

15

3

5

5

5.0

2.5

2.5

15

3

5

6

2.5

5..0

2.5

15

3

5

NaOH

CuS0

4

Trial 1

Trial

1

1

12.0

9.0

1

1

14.5

12.0

1

1

17.0

18.5

1

1

20.5

21.5

1

1

24.0

25.8

1

1

32.0

32.0

1

1

47.0

48.5

1

1

83.0

86.0

2

PIPETTE

5 ml.

SUPER-

7'

1.0

6.5

2.5

15

3

5
NATANT

8

0

7.5

1:----

2.5

HYDROLYSIS

15

-----t

3

5

+-STOP R!ACTION--i

~--'- - BIURET REACTION - - - - - - i

-1$aliquot was made up to 10 ml. 'Vo1ume as shown.

Fifteen DIl. of casein

solution, prepared as described. abO"1e, were added to eaoh test tube.
'-

These tubes

'W'el"e

then placed in a water bath at

38 degrees Centigrade for

two hot1l'8.
The degree of hydrolysis was determined by measuring the quantity of
protein

~olys1a

products produced. A set of ser1ally' nlJlbered tubes,

eaoh containiDg .3 ml. ot 10% trichloracetic acid was prepared. Fift ml.
of the contenta of the respeotive tubes oontaining the digestion mixture
were added to the prepared tr1cbloracetic acid-eonta1n1ng tubes.

The

tubes were mixed b:r inversion and allowed to stand at rOClll temperature for
10 minutes.

Th1a procedure stopped the hydrolysis reaction of the enzl'Dle

and substrate.

The tubes were then centrifuged at

3,500 r.p ... for 20

minutes. !.he supernatant was pipetted into another set of identically'
nUllbered tubes. The products of hydrol:ysis were then measured by the
huret method.
The V1chloracetic acid soluble material in the supernatant liquid
represented the products of hydrol)'sis. The percentage of trichloracetic
acid that is used in this procedure is critical. The trichloracetic acid
soluble material consists of polypeptide chains of a particular molecul.ar
weight whicb are the result

ot ch;ymotrypsin action upon the protein, casein.

Greater concentrations of triohloracetic acid would preoipitate not onl7
whole protein moleoules not yet digested but alao a portion of the polypeptide chains as well.

Lesser ooncentrations of trichloracetic acid

would tail to preoipitate intact molecules ot polypeptides. Therefore,

-16variations in the trichloracetic acid concentrations would intluenee subnquent analysis of the supernatant liClUid.

The supernatant liquid vas prepared for the Biuret reactionby' pipetting as much of the supernatant as possible into correspondingly n'\IUbered. tubes containing 1 JIll. of 30% Sodi. hydroxide.
JIll. of

S% wiT copper sulphate was added

up the gel which fOl'lled.

To these tubes 1

and the tubes were shaken to break

The tubes were then placed into a water bath at

38 degrees Centigrade for 10
uged for 10 ndnutell at 3,,00

~

r.p...

after which they were again centrif-

The Biuret color thus developed. was

measured b,. means o£ a Coleman Junior spectrophotaaeter. The fUter wu
set at

60" ~'.

The results were recorded in %transmisSion and were

charted on graph paper.

rIle reault1ng graphs are shown in figures 1 and 2. From th1B the
concentrations for the enzl'Measubstrate model were determined and set at

2.,

ml. of the so-called working ensyme solution and 15 ml. of casein

prepared as described above.
Sample tissue specimens obtained in the manner described above and
stored at -20 degl"ee8 Centigrade were used to dete1"!ll1ne the proper concen-

tration of the t.isaue homogenate to be used. The tissue was weighed on
an accurate laboratory balance to the nearest tenth of a mill1gra.
'!'he tissue was then homogenized in a Potter homogenizer, the pestle being fitted by a friction clutch

to an electric motor. '!'he hanogentzer

was subnerged in a melting iee vater bath during the entire time of hOlla-

genation.

The trial specbnens weighed 54.5 mg. and 61.9 mg.

These
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-19were"homogenized in 15 ml. and 17 ml. of saline solution in order to have
identical concentrations. A,liquots of the tissue homogenates were made
as shown in Table II.

Two and one-half ml. of the working enz,m,e were

added to each of the aliquots and allowed to stand at roam tempfl'.rature for
Each tube was

twenty minutes.

llI-~itated

once each minute. Fifteen ml. of

casein were then added to each aliquot and the tubes were incuba.ted for
two hours at ,38 degrees Centigrade.
utes.

Each tube was agitated every five min...

The reaction was then stopped by the addition of ,3 ml.. of 10% triThe sample was prepared for the Biuret reaction as

chloracetic acid.
described above.

The protocol for this procedure and the spectrophoto-

1Ieter readings are shown in Table II.
On the basis of these data it

wa.s decided that, it any inhibiting

1'actor or proteolytic factor was present in the tissue, it must be present in low concentration.

It was decided, therefore, to reduce the con-

In this

centrations of the reagents by a factor of five.

~

the relative

concentration of the tissue homogenate could be increased 'While using a
biopsy specimen within reasonable size. The tissuelsaline ratio for the
preparation of the h<ll'1ogenate was set at 37
saline.

Table

m

of tisauel 2 ml. of

mgJIl.

illustrates the protocol by which the protease ac-

tivity of the tissue specimens was measured.
reaction were again recorded as

%transmission

Junior spectrophotometer using a 605 A filter.

The results of' the Biuret
~

means of a Coleman

These readings were then

transcribed to optical density to facilitate statistical analysis.
Since pathological specimens were obtained from patients undergoing

TABLE II
TISSUE HOMOGENATE DETERMINATION

TABIE III
EXPERIMENT AL PROTOCOL

TABLE II
IN~TE

LET STAND 20 MIN. SHAXE

Il8nate

INCUBATE
CENTRIFUGE
WCANT

LET STAND
CENTRIFUGE

WOrking

Homo-

Tube

!SHAKE

MIX

38 C
SHAKE

saliDe
1 2

Casein

TCA 10% Digest

IDDma

%TRANSMISSION

NaOH

CUS0
4

Trial 1

Trial 2

1

1

26.5

31..0

1

1

28..2

38.0

1

1

28.2

32.0

1

1

28.8

32.5

28.0

32.5

I

,

1

5

0

2.5

2.5

15

3

5

2

4

1

3.5

2.5

15

3

5

3

J

2

4.5

2.5

15

3

5

4

2

J

5.5

2.5

15

3

5

5

0

5

7.5

2.5

15

3

5

1

1

6

0

7.5

10.0

0

15

3

5

1

1

PIP":TTE

I

5 MI.

SUPERNATANT

84.0

J
I

'I'MlLE III

MIX

IN~TE

L!'l' S'l'dD 20 MIl. SHAXE

38 C
SHAKE

SIllDe

.
!

Casein

TCA 10%

Digest

lfaOH

3.0

3

5

1

1

1

1

1

1

1!:Ds~

DJlAte

%'l'RAlfSMISSIOR

I

DECANT

WOrking

BolIO'I'IIbe

SHAKE INCUBATE
CENTRIFUGE

LET STAND
CEN'l'RIl'UGE

CuS04
!
I

Spec1Mn

1

0.5

0 ..5

PIPETTE
Coatro1

0

1 ..5

0 ..5

3.0

3

5

Blu1t

0

2.0

0

3.0

3

5

5 Ml..

SUPERNATANT

I

-21periodontal treatment, it was possible to obtain larger tissue specimens.

Therefore, it was decided to prepare two saJ'l'q)les fran each patho-

logic

speci~en.

One was set at the concentration designated in the pre-

ceding paragraph and the other was made at approximately two times as
great a concentration.

Thus the tissue:saline ratio of the homogenate

...ms about 75 mgm. of tissuet2 ml. of saline.

Results were recorded as

mentioned above.
Following preliminary exa:nination of these results, additional normal.
speciJUens were treated in the same msmer as described for the pathological specimens.

In order to make it possible to obtain sufficient tissue

for two samples of each nomal spec1Jnen, the reagent concentrations were
reduced by a. factor of two.

Thus the necessary tissue homogenate concen-

trations were made possible with a biopsy specimen of reasonable size.
Since the amount of the final solutions was reduced, it was necessary to
use a microcuvette with the spectrophotometer to record the results.
Because two different size cuvettes were ultimately used in this
study, it was necessary to establish a cuvette factor.

This was accom-

p11shed by subjecting the established enzymefsubstrate lnode1 to the procedure described.

The quantity of protein hydrolYSis products produced

't.rere measured in both types of cuvettes and recorded as %transmission.
These results "'Yere converted to optical density.
cuvette factor of 1.99 was calculated.

From these data a

This then enabled this inves-

tiga.tor to correlate the spectrophotometric readings obtained with the
microcuvette with those obtained with the larger cuvettea used in the
major portion of this stuq,.

CHAPl'ER IV
FINDImS AND STATISTICAL

ANALYSIS

The resu1ts of the e)::perimental procedure descr1.bed above have been
separated into five groups.

The spectrophotometric readings l;ere con-

verted into units of activity by multiplying each reading by 100.
data 'Here statistically analyzed.

The

The data of group I are shmm in Table

IV and the data of groups II, III, IV and V are shown in Table V.
Group I consists of the results of the
enzyme: substrate models.

hydrolYS~

of the control

As can be seen from Table III, a control model

was included each time that an experimental speciJnen ,.:as analyzed.
surr~ation

The

of these individual control models provided the control group

f or the experiment.

A total of sixteen control models were used in the

experiment and the resulting figures were grouped in a range frau. 2.3.66
activity units to

56.07 activity units. upon examination of these figures

in chronological order as can be seen from Table IV, it v-ras evident that

after subject
occurred.

15 a

sharp reduction in the amount of h~lirolytic activity

This 1:,3.5 been attributed by this investigator to a reduction

in the activity of the enzyme 'tvhich 'Was used in this study.

about t'tm months had elapsed from the beginning of
that noint.

A period of

e,~erimentation

to

After that time the activity of the enzyme was more constant.

Si."lce the change in enzyme activity l-1ould have the same effect as an alteration in enzyme concentration in the control models, a correction factor

'Has

deternined.

The control models of subjects fIl to #5 were averaged.

-22...

-23-

TABLE IV
CHOONOLOOICAL ORDER OF EXPERIMENTAL DATA

-23TABLE IV
SUBJ!'.CT

WEIGHT
mg.

mrITS OF ACTIVITY

CLINICAL

RIS'l'OLOGIC

EVALUATION

BVALUATION

CONTROL
50..86

BLANK

6 ..70

HCI40GENATE
&)50.72
b)45..84 (1)·

111

36.9

n01'll8l

norsal

12

70.7

normal

normal

" (2)

"

56.07
49.49 (3)

8.62
9.69

53.31

.)48.81
b)44.:37

13

33.2

normal

normal

14

29.3

normal

normal

"

"

53.46

115

30.9

normal

normal

"

n

53.76

116

27.6

normal

normal

32.79
31.43

4.58

32.79

,.,

69.4 perIodontitis

chronic
Inf'lammation

33.-72

7.57

a):31.88
b)33.72

18

49.7

"

"

n

"

.)33.72
b) 35..65

19

26.8

"

"

23.66
32.79

7.47
7.06

42.02

1110

73.6

"

"

29.16

8.36

a) 3O.J.0
b)27.57

1111

43.,3

"

"

28.4£)

8.62

35.65

112

30.2

37.68
32.79

7.57
6.05

37.68

1113 (4)

21.1

normal

normal

7.20
9.11

27.80

1114

23.7

normal

normal

26.61
27.80
25.97
25.97
n

"

28.40

1115

22.8

nOI'JIIBl

normal

"

"

29.59

"

"

!

(1) This Indicates that two samples of homogenate solutIon were treated Ind1v1d
ually and the readings recorded.
(2) This indicates that the preceding control and blank were used in the analysis of data of two or more specimens analyzed on the same da~
(3) This indicates that more than one control and blank were analyzed with
• partIcular group of subjects.
(4) This subject and following subjects were analyzed by a microcuvette method
and the data is corrected for the determined cuvette factor.
(

TABLE V
GROUPED EIPiRIMENT At DAT}I.

-24'fABLE V
GROUP II NORMAL SPECIMENS
UJlfITS OF ACTIVITY
SUBJECT WEIGHT
QONTB~

11

36.9

H~ENATE

26.76·

2:70·
24.J.3*

'"
118

49 •.7

"

31..8
33.72

112

70.7

"

113

33.2

29.·51·
26.05*

28.06*

119

26.8

23.66
32.79

42.02

14

29.3

"

28.J.4*

#10

73.6

29.J.6

30.10
27 ..57

15

30 •.9

"

28.30·

1/11

43.3

!8.40

35.65

16

27.6

32.79
31..43

32 ..79

#12

30..2

37 ..68
32 ..79

37.68

#13

21.J.

27.80

1114

23 ..7

26.61
27..80
25.97
25.97

"

#13

30.0

114

36.2

33.72
35.65

28..40

GROUP tv NORMAL SPECIMENS
UNITS OF ACTIVITY
SUBJECT WEIGw:r-*
CONTROL POMOGENATE

'

33.,72

69.4

23.35·
25 .. 69·

n
22..8
29 ..59
1115
*corrected for decrease in enzyme
activitl

..

GROUP III PATHOLOGIC SPECIMENS
UJlfITS OF ACTIVITY
SUBJECT WEIGHT
CONTROL POMOGP

GROUP V PATHOLOGIC SPECIMENS
UNITS OF ACTIVITY
SUBJECT WEIGH'l'··
CONTROL HOMOGENATE

119

U.4

2.3.66
32.79

28.40

26.61
27.80
25.97
25 ..97

20 ..38

1110

137.4

29.16

13.67

"

20 ..38

#11

77.8

28..40

24.36

37.68
32.7
18 ..71
1112
1.l.5
46.8
32.79
21.47
"
The concentration of the homogenate solution vas increased by a factor of
two by adjustment of the tissue weight and the saline solution.

-25the control models of subjects 116 to IllS were averaged.

The controls

which't:ere obta1ned during the period of greater eIl2yJ1e activity were reduced by a factor of 1.9 l1hich teras obtained by dividing these averages.

The

'·'ean

29.44

for the entire group of control mod,els af"ter this correction 'Has

units of activity.

The median was 28.78 unite of' activity. The

standard devte,tion for a small sample (Sx) was found to be 4.27 units of
activit,".

'!'he standa.rd error of the mean ( S.E.-i) for the control group

was 1.07 units of activity.
Specimens from normal gingiva which were ana17zed at the hOOlogenate
concentration of 37 mg. of tissue to 2 ml. of sallne were included in

Oroup II. A total of nine specimens varied in a range from 24.52 activity units to 32.79 activity units with a mean activity of 28.11 activity
units.

When each specimen was compared to its related control model,

little difference could be noted between the two.

shawed a slight intr1nsic proteolytic activit.y.

Seven of the group

7h1s was indicated by the

fact that the nuaber of activity units was higher for the specimen than
for the control.

'l\ro specimens exhibited a slight inhibitory action in

respect to their individual controls as evidenced by lcn-Jer activity readings.

fhooup

n

normal spec:ilJlens had a. median of

28.14 activity 1.mits.

!he standard deviation (Sx) was

2.58

mean ( S.E-i ) was 0.79 units.

The slight inhibitory activity, which is

units.

The standard error of the

indicated by a comperl,s on of' the means of group I and gr()Up II, is not
statistically ai.gnificant.

'!'his was determined by the a:r;plication of the

t test to these data. The results of the teat being t23 .. 1.000 which,

-26when applied to probabUity can be expressed as o.h

<:

P < 0 •.3.

In th1s

instance, a difference as large or greater would occur by chance between
three and four times out of ten.

The clinical eValuation of normal gin-

giva was substantiated by histological section in each case.
Seven gingival specimens which clinically and histologically' exhibited

ehrcnic inflmwtatory condition and whose tissue homogenate con-

l:1

centration

or

~

'7 rug.

of tissue to 2

ru.

saline were plaoed into group

nI.

these specimens one was eliminated from the f'1n.a1 analysis If'..aving a

total of six specimens.

The single specimen was discarded because of the

m.rer.1e behavior of the tissue homogenate upon the enzymelsubstrate mixture and of the respective control models.

cl1Ssed above each pa.thologic specimen

Uke the normal spec1mellfl discloeely related to its respec-

't1Y

t'-",e cnntrol. Four of the specimens showed an intrinsic proteolytic activityand two of the specimens had an inhibitory effect.
similarities were wmifest when the group

{lpoup III had a mean of 35.28 units of
units of a.ctivity.

l-1t:lS

considered i.n its entirety.

~1ctivity

'!'he standard. deviation

lUIS

fIm..rever, dis-

and a median of .35.17

5.26 units. The standard

error of the mean ( S. E-i ) was 1.91 un1 ts of act!vi ty.

The variance

between group III and group I has befn shawn to be statistically sign1.i'-

icant by means of the t test. Results of this test show t20 .. 2.666.

In respect ttl probability this ca.."1 be expressed as 0.02

<:.

P < 0.01.

'fheref'ore, the probability that a difference as great or grea.ter would.

oceur by chance is between one and two times in a hundred.
~~en

grour. II

a~ ~oup III

were compared, they were also fo~~ to

-27differ significantly. When the t test was applied, a result of

was obtained.

The probability was shown to be 0.01

tu .. 3.463

< P < 0.001 •. A differ-

ence of this ma.gnitude then would oceur by chance only between one in one
hundred times and one in one thousand times.
Group IV was CQIIlPrised of three specimens which were taken from sub-

jects who were included in group II.

These specimens .:for group IV were

actually a part of the original biopsy sample .trom a. subject in group II.
'!'he g1n~i.a1 tissue was histologically and clinically nom.al.

sue

hom~enate

enncentration, however, was increased two-fold.

The tis-

i!6.ch of'

the three aamp1. treated in this maDl'ler exhibited a. decrease in enzymatic a.ctivit,. in respect not only to its control model but especialJ. y to

its "mate" in group II. This we.a signified
Q,ctiv1ty unite observed.
tivit,-.

by a decrease in the number of

'!'he mean of this group was 20.74 units of ac-

The median was 20.38 units.

The standard deviation (

Sx )

was

0.88 mite of activity and the standard error of 'the mean (S.E.i) was

0.51 units of activity. Although group IV was

of a very small sample, the

probability that groups II and IV were of separate universes, was statiBtieal.ly greater than 0.001.

Onl:r in one in one thousand times would this

magnitude of difference occur by chance.
Fach ot the tour specimens in group V wae ala 0 taken from a particular
subject already- included in group III.

1nf'1amed gwiva.

The specimens were of chronically

The only variation again

the tisaue homogenate concentration.

'WaS

a two-fold increase in

The mean of 21.19 units of activity

dUtered greatly trom the mean of group nI which was 35.28 un1t..s of
activitYe

The standard deviation was 0.72 units and the standard error

of the mean was 0.51 uni tel of activit,..

The variation

b~tveen

these two

groupe was statistically sign1ticant as illustrated by the results of the
t test. For a value of the relative deviate ( sIx ) equal to 3.522 t8

was shown to be 0.01 < P < 0.001. Therefore, a difterence as great or
greater would occur by chance between one in one hundred and one in one
th01ll!land times.
Groups IV and V were also analyzed statistically for their relation-

ship to each other.

Differences between them were found not to be sig-

n1ticant. The value ot the relative deviate was

0.1264.

When this is

applied to the t test tor five degrees ot freed<lJl, the probabil1t;r of
this occurring by chance 18 greater than nine tau out of ten.

CHlPrER "

DISCmSIOI
Turning for a m(lllent to the first chapter of this report, it w1l1 be
remembered that an important aspect of this study was the develoJDent o:t
a method of investigation.

!he protocol described in Chapter III illus-

trates a method which has proven to be feasible for measuring proteolytic
enzym. activity or proteolytic enzyme inhibitor activity in gingival tissues. The usefulness of the method to measure proteolytic activity wu
shown by the resulta of group III. The abillt)" to detect proteolytic en.,.e inhibition was evident in groups IV and V.

The results of the con-

trol group, group I, were obtained through the application of methods described in the literature and by means of studies of
by

c~otrypsin.

~ro1ysis

or casein

The latter were performed b)" accepted procedures. Sig-

nificant d1.fferences were obtained between group I and groups III, IV,
and V in which the tissue hOllogenates were the

onl.T variants.

Once again, let us classify the five groups of data.

Group I con-

sists of the results of the bJrdrol.ysis of the control enzymet substrate
models.

The constituents or the control models are shawn in Table III.

'!'he results

or the effect of tissue homogenates of normal gingival speci-

mens upon an ens)'Jlle

I

substrate model were included in Oroup II. The

homogenate concentration of this group was set at 37

JUg.

of tissue to 2 ml.

ot saline. Group III was identical to Group II except that the effects
of chronically inflamed gingivae were measured instead of nomal gingivae.

In Group IV the effects of normal gingival hanoganatea upon the enzyme t

-29-

substrate model were measured.

The gingival specimens were obtained fraa

subjects already included. in Group II.

However, the concentration of the

hmogenate solution was now increased by a factor of approximately two
by increasing the weight of the specimen and adjusting the emomt of

saline in the mixture.

The results of Group V were obtained fran chron-

ical17 inflamed specimens of subjects included in Group lll. The homogenate concentration of the specimens was increased in the same manner lIB
in Group IV.

Although fiTe d1atinct group1l were delineated in Chapter lV, it will
be necessary to correlate these groups to e~t the salient ideas de-

rived from this investigation.

Initially, it would seem that the normal

tissue spec:iJltens in group II had no effect upon the enss)'Jlle
during the period of incubation.

m

c~otrypain

The spectrophotanetric readings o£ group

indicated a greater &momt of products of

~0lJ'81a

in the homogenate

enzyme substrate Ddxture as compared to the control group. Since these
differences were statistically significant, an intrinsic proteolytic enssyme with an action upon the substrate, casein, was present in the int'lam_tory tissue specimens of group III.

10 evidence of a possible ellQlU

and enzyme inhibitor relationship can be shown lUltU the results of groups

IV and V are simultaneously considered.
Group IV samples demonstrated a significant inhibitory effect upon

the elllS,.e

n.

c~oiiJ:7pel1n

when they were compared to their "mates II in group

This was true not only when the groups were considered as a whole

and analyzed statistically but also when the "mated" samples were con...

-31lidered individually between groups'. These results can be seen by canparing these groups in Table V.

This same phenmenon was evident be-

tween groups III and V as shown in Table V.

'1'0 what can "'these differences be attributed?

'l'he presence of an

enzymatic inhibitor,- factor is definitely evident.

'!'he enzyme inhibition

can be detected after a change in concentration of the tissue samples.
This may indicate that at the lower concentrations, the enzyme inhibitor
effect

or the tissue

was not measurable by this method.

However, by in-

creasing the concentration of the tissue homogenate the presence of an inhibitor could be dem.0n8trated in both n01'llal and inflamed tissue.
this conclusion alone does not provide an

cant differences between groups
trinsic proteolytic activit,..
from group

n

m

and V.

adeq~te

Group

Yet,

reason for the signifi-

In

demonstrated an in-

These data were Significantly different

as well as the control group, group I.

When the concentra-

tion of the tissue homogenates was increased as in groups I'f and V, the
inhibitor activity of both groups showed no Significant dUferenees.

In

fact, the differences in the levels of' proteolytic enz)'JIle activityof'
normal and inflamed tissues were no longer apparent.

This would sean to

indicate a higher degree of inhibitor acti'Vity in inf'1amed tissues than

in normal tusuea.
On the other hand, the st'0d7 may be understood. more clearly by examining it from another aspect.

'the data from groups IV and V 1n<.iicate

the presence of an inhibitor in both normal and chronically 1nf'1amed gingival tissues.

The fact that the normal. and inflamed tissues of groups

II and III, which 'Here analyzed at a lower concentration" did not shaw
the presence of an enzyme inhibitor can be attributed to a balanced relationship of en!yme to inhibitor.

This relationship between enzyme and

inhibitor might not be numerically equivalent.

That is" it might require

more inhibitor to counteract a given amount of enzyme.
Beems to be

In fact" this

true when the normal and pathological groups of lower tissue

concentrations are considered in relation to the normal and pathologic
groups of higher tissue concentraticn.

If, for instance" a relationship

of one part enzJ1l1le to two or more parts

enz,.. inhibitor produced the zoe-

sruts of group II or III" then" by increasing the concentration of the
tissue homogenate of the same subject, the net result would be one of absolute enzyme inhibition.
.3 and

This is Ulustrated in the diagrams in figures

4.

--

An in vivo interpretation of an enzyme
nature is depicted in figure.3.

.!!! ....v1;;..;tro;;;;..;;. situation

Figure

I

inhibitor mechanism of t.his

4 depicts an

a:na~1s

of the

as applied to this experiment. It can be seen that by

keeping the amount of the e::lperimental enZ}'me, chymotrypsin" constant
while varying the concentration of the tissue components" the abs olute
inhibitor activity is altered.

This alteration under experimental

man-

ipulation would be depicted as an appearance of inhibitor activity.

!his

inhibitor activity would be approximated to the difference between the

--

absolute inhibitor activity in vivo and the absolute inhibitor activity

Therefore, a.na1.yzing the prabl_ in this manner" the results of
groups II and IV becaae clearer.

'!'hat is, in normal. gingival tissue a
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-35balanced enzyme-antienzyme mechanism would shaw no effect upon the enzyme substrate mixture.

Yet, the same tissue specimen at greater homo-

genate concentration would produce an inhibitory effect upon a similar
enzyme substrate mixture.

The results of groups

m

and V seem to in-

dicate tha:f:, an enzyme - inhibitor relationship would be a dynamic fiuctuat1ng system just as 1t is true of 'Il18!W of the bodily" processes.

In

general the tissues in group III were fmmd to exert an additive proteo1~rtic

I.

effect upon the en!lyme substrate mixture when compared to group

Yet, upon increasing the tissue homogenate concentration, an inhibi-

tion

~:ras

ences

evident in amounts grea.t enough so that no significant differ-

be~Teen

groups IV and V could be found.

It will be remembered that

the "mates" of these grours, groups II and TIl differed significantly.
'!'hose find1ngs are a.ttributed to an overcompensation of the inl'.J.bitory
.factors in response to the proteolytiC enzymes produced in the inflammatory process.
These ideas have basis iri the literature. West and Hilliard (1949)
indicated that serum proteolytic inhibitor levels remainf'd elevated dur..
ing cert.91n disease states and when the tissues were undergoing an ad-

justment to a nonna.l state.

'fokuda (1959) showed that monocytes sub-

jected to an antigen-antibod.v res.ction secreted a protease and then a
protease inhibitor.

That latter work would seem to indicate the presence

of a time relationship in that mechanism not only betlreen the proteases
and the inhibitors that 'Were produced 1:'u.t aIao between cells or grr.ups

of cells which "rere subj0cted to injury.

In this ""aY nei.ther enz:YJlle nor

-36inhibitor would act alone.

Therefore, it is understandable that in a

proteolytic enzyme and inhibitor mechanism. of' this type, a relationship
such as the one described in this present study could produce the results that were obtained.
Fran this investigation questions arise which must be answered by
further research.
de~ree

'l'he nature of the inhib1tor must be determined.

The

to which the inhibitor,y factor measured in tissues is influenced

by the proteolytic enzyme inhibitors in serum should be elucidated.

Are

results such as those obtained in groups II and IV of this study attributable to the fact that even so-called normal gingival tissues exbibit

a chronic

in.fl8lllnation to varying degrees?

Only through a continuing

quest for new ideas can lmowledge in any field progress.

CHAPl'ER VI
SUMMARY AND CONCImIONS
'!'he purpose of this study

lTaB

to investigate the activity of pro-

teolytic enzymes in clinically and histologically normal gingival tis. sues as irell as chronically inflamed gingivae.

The experimental pro-

cedures were designed to demonstrate any possible relationship of proteolysis to proteolytic enzyme inhibition.

Due to a minimum o:t information

in the literature regarding a specific method of investigation.. the devel-

opment of such a method was considered important.
Chapter III describes a method of investigation by which proteolytic enzyme activity or proteolytic enzyme inhibition of a gingival tissue specimen was measured.

The procedure required homogenation of the

tissue and incubation of the homogenate with a known Blllotmt of a proteolytic enzyme.

C~otrypsin l-ras

used in this study.

The mixture

or

enzyme and homogenate was then incuba:lied with a known quantity of substrate for the enzyme.

The products of hydrolysis were then measured

colorimetrically after employing the Biuret reaction.
strate control

~odels ~re

byrne

I

sub-

employed as a basis for determining the pro-

teolytic or inhibitory activity of the tissue specimena.

The method was

'Workable using relatively small tissue samples.
Ni..."18 normal gint';ival specimens and six chronicallY infla:a1led gin-

gival specimens from fifteen subjects
described..

w~re

a.na.lyz.ed using the method

Significant dif.ferences were demonstrated between the

-37-

· -38atteets of normal and inflamed R'ingivae upon the enz,me

mixture.

I

substrate

This was attributed to the proteolytic activity of the inflam-

matory proc€ss.

The presence of an L"lhibitor of chymotrypsin

strated in both noma1 and chronically inflamed hunum

loJaS

gi~ivae.

demon'!'his wu

accomplished by varying the concentration of the homogenate of tissue
specimens from individual subjects.

'!'he relationship bet.-reen an enzyme

and its inhibitor, which could produce the results that are reported in

Chapter '!V, nas discussed.
The following conclusions seem to be justified on the basis of the

res ults of this

st~1

1) '!'he method of investigation which

t-taS

developed is applicable

to thia study.

2) 'n'te presence of a proteo1J1tic enzl'Jlle inhibitor was demonstrated
both in normal. and inflanted gingivae.

3) '!'he tissues fran. 1n1'1amed ging1va seem to have a. higher proteolytic enzYMe 1nh1.bitor level than do corresponding samples freD
normal ging1'ft.

This conclusion is based on the observation

that the additional proteolytie component ascribed to the hatlogenate sample is minimised or eliminated bY' elevating the tissue homogenate level in the experimental procedure. Suoh a re-

versal in proteolytic behavior 'Was not demonstrable for the
normal tissue homogenates.
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